Not Rated
|
Fund Size
(0.02% of Investment in Category)
|
Expense Ratio
(2.13% Category average)
|
| Period Invested for | ₹10000 Invested on | Latest Value | Absolute Returns | Annualised Returns | Category Avg | Rank within Category |
|---|---|---|---|---|---|---|
| 1 Week | 21-Nov-25 | 10182.00 | 1.82% | - | 0.63% | 8/237 |
| 1 Month | 28-Oct-25 | 10327.70 | 3.28% | - | 0.00% | 3/240 |
| 3 Month | 28-Aug-25 | 10520.60 | 5.21% | - | 4.84% | 97/237 |
| 6 Month | 28-May-25 | 10742.20 | 7.42% | - | 5.86% | 59/226 |
| YTD | 01-Jan-25 | 9789.80 | -2.10% | - | 4.55% | 165/211 |
| 1 Year | 28-Nov-24 | 10558.40 | 5.58% | 5.58% | 4.70% | 75/199 |
| 2 Year | 28-Nov-23 | 14307.60 | 43.08% | 19.59% | 17.66% | 56/155 |
| Since Inception | 14-Dec-22 | 17449.40 | 74.49% | 20.70% | 12.46% | 23/219 |
| Period Invested for | ₹1000 SIP Started on | Investments | Latest Value | Absolute Returns | Annualised Returns |
|---|---|---|---|---|---|
| 1 Year | 28-Nov-24 | 12000 | 12718.37 | 5.99 % | 11.22 % |
| 2 Year | 28-Nov-23 | 24000 | 26780.27 | 11.58 % | 10.9 % |
If sold after 1 year from purchase date, long term capital gain tax will be applicable. Current tax rate is 12.5%, if your total long term capital gain exceeds 1.25 lakh. Any cess/surcharge is not included. If sold before 1 year from purchase date, short term capital gain tax will be applicable. Current tax rate is 20%. Any cess/surcharge is not included in the 20%.
Top 10 Stocks in Portfolio
| Stock Invested in | Sector | Value(Mn) | % of Total Holdings | 1M Change | 1Y Highest Holding | 1Y Lowest Holding | Quantity | 1M Change in Qty |
|---|---|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries Ltd. | Pharmaceuticals | 201.4 | 22.18% | 0.57% | 25.51% (Apr 2025) | 21.61% (Sep 2025) | 1.19 L | -0.25 k |
| Divis Laboratories Ltd. | Pharmaceuticals | 96.8 | 10.66% | 1.36% | 11.01% (May 2025) | 9.3% (Sep 2025) | 14.36 k | -27.00 |
| Cipla Ltd. | Pharmaceuticals | 95.5 | 10.51% | -0.37% | 11.42% (Aug 2025) | 10.2% (Dec 2024) | 63.59 k | -0.13 k |
| Dr. Reddys Laboratories Ltd. | Pharmaceuticals | 82.5 | 9.08% | -0.51% | 10.28% (Dec 2024) | 9.08% (Oct 2025) | 68.88 k | -0.14 k |
| Lupin Ltd. | Pharmaceuticals | 53.7 | 5.91% | -0.03% | 6.89% (Dec 2024) | 5.7% (Jul 2025) | 27.35 k | -56.00 |
| Torrent Pharmaceuticals Ltd. | Pharmaceuticals | 42.1 | 4.64% | -0.21% | 4.85% (Sep 2025) | 3.83% (Dec 2024) | 11.83 k | -21.00 |
| Laurus Labs Ltd. | Pharmaceuticals | 41.9 | 4.61% | 0.41% | 4.61% (Oct 2025) | 2.87% (Nov 2024) | 43.92 k | -89.00 |
| Aurobindo Pharma Ltd. | Pharmaceuticals | 36 | 3.97% | 0.07% | 4.55% (Nov 2024) | 3.67% (Aug 2025) | 31.62 k | -63.00 |
| Alkem Laboratories Ltd. | Pharmaceuticals | 35.1 | 3.86% | -0.07% | 3.93% (Sep 2025) | 3.31% (Jul 2025) | 6.37 k | -9.00 |
| Glenmark Pharmaceuticals Ltd. | Pharmaceuticals | 32.2 | 3.55% | -0.24% | 3.93% (Jul 2025) | 2.69% (Apr 2025) | 17.03 k | -33.00 |
| Name | Type of Instrument | Weight (%) |
|---|---|---|
| TREPS | TREPS | 0.67% |
| Net Receivables | Net Receivables | -0.65% |
Ratios calculated on daily returns for last 3 years (Updated as on 31st October, 2025)
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| Nippon India Taiwan Equity Fund - Regular Plan - Growth | NA | 421.51 | 3.67 | 17.90 | 53.98 | 58.76 | 36.99 |
| Aditya Birla Sun Life International Equity Fund - Regular Plan - Growth | NA | 273.51 | -0.22 | 4.72 | 16.52 | 29.87 | 15.41 |
| Franklin Asian Equity Fund - Growth | NA | 297.12 | -1.25 | 9.54 | 18.32 | 22.89 | 13.30 |
| Quant BFSI Fund - Regular Plan - Growth | NA | 680.73 | 1.47 | 11.19 | 16.24 | 22.52 | 0.00 |
| HDFC Transportation and Logistics Fund - Regular Plan - Growth | NA | 1733.63 | -0.77 | 5.55 | 19.99 | 19.71 | 0.00 |
| ITI Banking and Financial Services Fund - Regular Plan - Growth | NA | 333.18 | 2.83 | 12.32 | 9.66 | 19.18 | 13.62 |
| DSP Banking & Financial Services Fund - Regular Plan - Growth | NA | 1518.73 | 1.34 | 10.78 | 7.35 | 19.13 | 0.00 |
| Nippon India Japan Equity Fund - Growth | NA | 292.35 | -0.39 | 2.73 | 10.55 | 18.85 | 15.16 |
| SBI Banking & Financial Services Fund - Regular Plan - Growth | NA | 9273.44 | 2.47 | 10.59 | 11.34 | 18.48 | 19.71 |
| Mirae Asset Banking and Financial Services Fund - Growth | NA | 2130.33 | 2.89 | 11.40 | 10.00 | 18.11 | 17.43 |
Out of 175 mutual fund schemes offered by this AMC, 10 is/are ranked 5 * , 8 is/are ranked 4 * , 15 is/are ranked 3 * , 5 is/are ranked 2 * , 2 is/are ranked 1 * , and 135 schemes are not ranked. See more about AMC
| Scheme Name |
Crisil Rank |
Asset Size (Cr) |
1M |
3M |
6M |
1Y |
3Y |
|---|---|---|---|---|---|---|---|
| ICICI Prudential Large Cap Fund - Growth | 5 | 75863.08 | 1.58 | 5.63 | 7.01 | 9.54 | 17.99 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 1.11 | 6.57 | 8.49 | 15.77 | 19.22 |
| ICICI Prudential Multi-Asset Fund - Growth | 3 | 71900.48 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| ICICI Prudential Balanced Advantage Fund - Growth | 2 | 68449.94 | 0.62 | 3.92 | 6.48 | 11.31 | 13.53 |
| ICICI Prudential Value Fund - Growth | 5 | 57934.73 | 1.99 | 6.28 | 7.79 | 11.42 | 21.22 |
| ICICI Prudential Liquid Fund - Growth | 3 | 50120.55 | 0.49 | 1.43 | 2.92 | 6.58 | 6.96 |
| ICICI Prudential Equity & Debt Fund - Growth | 5 | 48071.30 | 0.48 | 4.50 | 6.92 | 12.10 | 18.96 |
| ICICI Prudential Money Market Fund - Growth | 4 | 35011.13 | 0.53 | 1.51 | 3.22 | 7.55 | 7.54 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.01 | 6.25 | 6.55 | 9.31 | 13.52 |
| ICICI Prudential Nifty 50 ETF | 5 | 34935.53 | 1.01 | 6.25 | 6.55 | 9.31 | 13.52 |